No definition available.
Congenital obstructive defects of renal pelvis and congenital malformations of ureter
EFO MESH Endpoint Browser PheWeb
Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
757 |
4. Check minimum number of eventsNone |
757 |
5. Include endpointsNone |
757 |
6. Filter based on genotype QC (FinnGen only) |
757 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_URINARY_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[0-4]
- Name in latin
- Defectus obstructivi congeniti pelvis renalis
Similar endpoints
↥List of similar endpoints to
Congenital obstructive defects of renal pelvis and congenital malformations of ureter
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the urinary system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10797 | 5507 | 5270 |
| Only index persons | 8505 | 4638 | 3867 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.16 | 0.15 |
| Only index persons | 0.16 | 0.17 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 2.92 | 4.58 | 1.05 |
| Only index persons | 4.71 | 6.19 | 2.94 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 757 | 486 | 271 |
| Unadjusted period prevalence (%) | 0.15 | 0.17 | 0.12 |
| Median age at first event (years) | 23.50 | 23.67 | 23.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 660
- Matched controls
- 6598
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q62.10
ICD-10 Finland
Congenital unilateral occlusion of the pelvic ureteral junction
+∞
279.7
248
*
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
+∞
233.6
210
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
111.3
157.1
167
20
UKC02
NOMESCO Finland
Cystoscopy
13.5
135.4
260
302
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
9.9
107.5
244
368
Q62.0
ICD-10 Finland
Congenital hydronephrosis
+∞
106.2
99
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
88.5
101.0
111
15
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
294.0
100.8
100
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
14.0
93.9
170
159
KAH41
NOMESCO Finland
Percutaneous endoscopic pyeloureteroplasty with division of ureteropelvic junction
523.1
93.8
91
*
J01EA01
ATC
trimethoprim; systemic
5.5
81.2
315
941
KBV52
NOMESCO Finland
Cystoscopic injection therapy for vesicourethral reflux
842.5
78.0
75
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
32.5
75.5
100
36
Q62.5
ICD-10 Finland
Duplication of ureter
+∞
66.8
63
*
KA1FN
NOMESCO Finland
Isotope renography
81.7
65.6
73
10
G04AC01
ATC
NA
17.4
59.5
96
64
KA1AE
NOMESCO Finland
Kidney ultrasound examination
21.5
53.8
80
42
N13.7
ICD-10 Finland
Vesicoureteral-reflux-associated uropathy
195.7
52.8
54
*
1530
FHL
Urethrocystoscopy
31.9
52.2
69
24
J01XE01
ATC
nitrofurantoin; oral
21.9
46.8
69
35
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
40.6
44.9
56
15
KBH20
NOMESCO Finland
Replantation of ureter
467.9
44.8
44
*
KAH40
NOMESCO Finland
Pyeloureteroplasty with division of ureteropelvic junction
+∞
42.1
40
*
J01MA02
ATC
ciprofloxacin; systemic
3.3
39.9
277
1200
UKB02
NOMESCO Finland
Retrograde ureteroscopy
68.8
39.6
45
7
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
38.5
258
1083
5937A
ICD-9 Finland
Other disorders of kidney and ureter, Vesicoureteric reflux
42.0
38.0
47
12
KC1JB
NOMESCO Finland
Miktiocystography with X-ray
388.2
37.4
37
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.1
35.7
160
481
XKD00
NOMESCO Finland
Uroflowmetry
4.9
35.7
128
309
Q62.2
ICD-10 Finland
Congenital megaloureter
+∞
34.7
33
*
Q62.18
ICD-10 Finland
Other specified atresia and stenosis of ureter
+∞
33.6
32
*
N18.8
ICD-10 Finland
Other chronic renal failure
17.7
32.5
51
31
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
18.8
31.9
49
28
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
+∞
31.5
30
*
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
32.6
30.7
40
13
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
30.0
182
688
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.8
29.9
107
255
ZXE20
NOMESCO Finland
More than three and less than five hours
3.8
29.6
139
429
Q62.3
ICD-10 Finland
Other obstructive defects of renal pelvis and ureter
+∞
29.4
28
*
204
Kela drug reimbursment
Leukemia lymphatica
9.6
29.4
61
69
Z94.0
ICD-10 Finland
Kidney transplant status
23.6
28.2
40
18
5910A
ICD-9 Finland
Hydronephrosis[HYDRONEPHROSIS]
293.4
28.0
28
*
A11CC03
ATC
alfacalcidol; systemic
14.0
27.4
47
36
KH1AD
NOMESCO Finland
CT of urinary organs
9.0
26.1
56
67
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
42.0
26.0
32
8
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
16.7
25.8
41
26
KH1EE
NOMESCO Finland
Urologic ultrasound examination
37.3
25.4
32
9
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
25.4
287
1562
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
14.9
25.2
42
30
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
18.2
24.7
38
22
N20.0
ICD-10 Finland
Calculus of kidney
13.1
24.4
43
35
KA3GB
NOMESCO Finland
Retrograde pyelography
248.6
23.8
24
*
R4110
NOMESCO Finland
Physiotherapy
2.7
23.6
205
958
KBV10
NOMESCO Finland
Removal of stent from ureter
37.8
23.2
29
8
Q62.11
ICD-10 Finland
Congenital bilateral occlusion of the pelvic ureteral junction
+∞
23.1
22
*
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
+∞
23.1
22
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
22.8
254
1354
ZXC96
NOMESCO Finland
Robot assisted procedure
13.7
22.7
39
30
127
Kela drug reimbursment
Transplant complication
12.8
22.6
40
33
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
28.5
22.4
30
11
A12AA04
ATC
calcium carbonate; oral
20.4
22.3
33
17
N30.0
ICD-10 Finland
Acute cystitis
3.0
21.8
141
545
KA3EB
NOMESCO Finland
Antegrade pyelography
51.8
21.3
25
5
N18.0
ICD-10 Finland
End-stage renal disease
25.2
21.0
29
12
XKC03
NOMESCO Finland
Water cystometry
7.9
20.0
46
62
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
30.0
19.8
26
9
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.6
19.8
43
53
ZXE00
NOMESCO Finland
One hour or less
2.2
19.7
292
1751
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
17.4
19.3
30
18
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.9
18.1
29
19
R31
ICD-10 Finland
Unspecified haematuria
4.3
17.8
69
176
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
68.6
17.8
20
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
+∞
17.8
17
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
36.1
16.8
21
6
Q62.8
ICD-10 Finland
Other congenital malformations of ureter
+∞
16.7
16
*
KH1CB
NOMESCO Finland
Urography with X-ray
92.5
16.6
18
*
R50.9
ICD-10 Finland
Fever, unspecified
2.5
16.3
142
644
ZXD05
NOMESCO Finland
Urgent procedure
2.2
16.2
211
1171
L04AA06
ATC
mycophenolic acid; systemic
8.9
16.1
34
40
Q62.6
ICD-10 Finland
Malposition of ureter
+∞
15.7
15
*
TKC20
NOMESCO Finland
Catheterisation of bladder
4.2
15.6
61
157
U14
ICPC
Kidney symptom/complaint
12.7
15.5
27
22
N28.8
ICD-10 Finland
Other specified disorders of kidney and ureter
39.1
15.5
19
5
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
29.4
15.3
20
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
20.6
15.2
22
11
WX402
NOMESCO Finland
General anaesthesia
2.4
14.8
141
671
ZXA00
NOMESCO Finland
Right side
2.3
14.8
153
756
Q62.12
ICD-10 Finland
Congenital occlusion of ureterovesical orifice
+∞
14.6
14
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
14.6
14.6
24
17
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
13.9
124
569
B03XA02
ATC
darbepoetin alfa; parenteral
12.4
13.7
24
20
KAH62
NOMESCO Finland
Endopyelotomy
+∞
13.6
13
*
J01CA08
ATC
pivmecillinam; oral
1.9
13.4
271
1765
TK800
NOMESCO Finland
Hemodialysis
9.0
13.1
27
31
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
17.1
13.0
20
12
Z3226
NOMESCO Finland
Physiotherapist
2.2
12.9
147
757
J01DA01
ATC
[U] cefalexin; systemic
1.8
12.7
382
2829
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
12.6
12.7
22
18
7187
FHL
Ureterohydroplasty due to reflux, for example
132.4
12.5
13
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
132.4
12.5
13
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
38.3
12.2
15
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
38.3
12.2
15
*
XF602
NOMESCO Finland
Bloodpressure monitoring
16.3
12.2
19
12
KAC00
NOMESCO Finland
Nephrectomy
18.5
12.1
18
10
G04BD04
ATC
oxybutynin; oral, transdermal
4.3
12.0
44
107
7143
FHL
Pyeloureteroplasty
47.6
11.9
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
11.7
71
258
V03AE01
ATC
polystyrene sulfonate; oral
16.8
11.7
18
11
7532A
ICD-9 Finland
Congenital anomalies of urinary system, Obstructive defects of renal pelvis and ureter
66.2
11.6
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
11.6
55
168
Q61.0
ICD-10 Finland
Congenital single renal cyst
+∞
11.5
11
*
KAH30
NOMESCO Finland
Pyeloureteroplasty without division of ureteropelvic junction
+∞
11.5
11
*
J01MA06
ATC
norfloxacin; oral
2.7
11.5
79
313
ZXD20
NOMESCO Finland
Day surgery
2.5
11.2
89
382
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
25.5
11.2
15
6
Z2221
NOMESCO Finland
Medical doctor
1.9
10.9
193
1175
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
+∞
10.4
10
*
7534X
ICD-9 Finland
Congenital anomalies of urinary system, Other specified anomalies of ureter
+∞
10.4
10
*
Q60.3
ICD-10 Finland
Renal hypoplasia, unilateral
+∞
10.4
10
*
KDD52
NOMESCO Finland
Urethroscopic excision of urethral valve
+∞
10.4
10
*
Z3231
NOMESCO Finland
Registered nurse
1.9
10.4
201
1263
B03XA01
ATC
erythropoietin; parenteral
12.3
10.4
18
15
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
19.1
10.3
15
8
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
19.1
10.3
15
8
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
23.8
10.3
14
6
N30.9
ICD-10 Finland
Cystitis, unspecified
3.3
10.1
51
164
ZXA05
NOMESCO Finland
Left side
2.1
10.1
132
712
137
Kela drug reimbursment
Uraemia requiring dialysis
11.5
10.1
18
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
10.0
149
850
L04AD01
ATC
ciclosporin; systemic
5.8
9.6
26
46
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
7.7
9.5
21
28
7219
FHL
Other measure in this category
101.4
9.4
10
*
V03AE02
ATC
sevelamer; oral
30.5
9.4
12
*
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
+∞
9.4
9
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
+∞
9.4
9
*
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
+∞
9.4
9
*
KCF02
NOMESCO Finland
Transluminal endoscopic removal of foreign body from bladder
+∞
9.4
9
*
N26
ICD-10 Finland
Unspecified contracted kidney
+∞
9.4
9
*
N20.1
ICD-10 Finland
Calculus of ureter
4.4
9.2
32
75
V03AE03
ATC
lanthanum carbonate; oral
37.2
9.0
11
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
24.4
8.9
12
5
5990C
ICD-9 Finland
Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM RECIDIVANS]
24.4
8.9
12
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.5
8.9
40
119
5990B
ICD-9 Finland
Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM ACUTA]
9.7
8.8
17
18
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.7
200
1315
B05DB
ATC
Hypertonic solutions
16.5
8.6
13
8
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.7
8.6
28
62
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
27.9
8.5
11
*
KBV42
NOMESCO Finland
Cystoscopic incision or excision of ureterocele
91.2
8.4
9
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.6
8.4
36
103
Q61.40
ICD-10 Finland
Renal dysplasia of a kidney (multicystic)
+∞
8.3
8
*
7533X
ICD-9 Finland
Congenital anomalies of urinary system, Other specified anomalies of kidney
+∞
8.3
8
*
Q61.99
ICD-10 Finland
Cystic kidney disease, unspecified
+∞
8.3
8
*
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
9.6
8.3
16
17
J01MA12
ATC
levofloxacin; systemic
2.1
8.2
91
458
B34.9
ICD-10 Finland
Viral infection, unspecified
3.1
8.1
43
145
N30
ICD-10 Finland
Cystitis
2.5
8.1
62
262
H05BX01
ATC
cinacalcet; oral
22.3
8.0
11
5
N20.9
ICD-10 Finland
Urinary calculus, unspecified
5.3
7.9
23
45
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
7.8
225
1569
5AB14
NOMESCO Finland
NA
18.6
7.6
11
6
KDV20
NOMESCO Finland
Submucous urethral injection
25.3
7.6
10
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
81.0
7.4
8
*
N28.1
ICD-10 Finland
Cyst of kidney
13.6
7.4
12
9
WZC30
NOMESCO Finland
Teaching
2.2
7.3
72
342
Q62.1
ICD-10 Finland
Atresia and stenosis of ureter
+∞
7.3
7
*
7186
FHL
Ureteroplasty, narrowing and resection (includes neoimplantation)
+∞
7.3
7
*
KBJ00
NOMESCO Finland
Cutaneous ureterostomy
+∞
7.3
7
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
30.4
7.2
9
*
Z99.2
ICD-10 Finland
Dependence on renal dialysis
20.3
7.1
10
5
B05DA
ATC
Isotonic solutions
10.2
7.1
13
13
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.0
236
1705
R39.1
ICD-10 Finland
Other difficulties with micturition
5.1
6.8
20
40
N13.2
ICD-10 Finland
Hydronephrosis with renal and ureteral calculous obstruction
40.5
6.8
8
*
3076C
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[YÖ- JA PÄIVÄKASTELU]
40.5
6.8
8
*
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
16.9
6.8
10
6
N19
ICD-10 Finland
Unspecified kidney failure
5.3
6.7
19
37
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.7
6.6
42
160
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
6.5
73
370
Q42.2
ICD-10 Finland
Congenital absence, atresia and stenosis of anus with fistula
70.5
6.4
7
*
R33
ICD-10 Finland
Retention of urine
3.0
6.4
35
122
Z49.0
ICD-10 Finland
Preparatory care for dialysis
14.5
6.4
10
7
C08CA01
ATC
amlodipine; oral
1.7
6.3
131
823
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
6.3
50
215
4AA09
NOMESCO Finland
NA
18.2
6.3
9
5
7536A
ICD-9 Finland
Congenital anomalies of urinary system, Atresia and stenosis of urethra and bladder neck[OBSTRUCTIO URETHRAE ET COLLI VESICAE CONGENITA]
+∞
6.3
6
*
Q61.48
ICD-10 Finland
Nonspecified renal dysplasia
+∞
6.3
6
*
7188
FHL
Ureteroneocystostomy
+∞
6.3
6
*
H05BX02
ATC
paricalcitol; systemic
+∞
6.3
6
*
KAD10
NOMESCO Finland
Heminephrectomy
+∞
6.3
6
*
Q62.4
ICD-10 Finland
Agenesis of ureter
+∞
6.3
6
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
7.1
6.2
14
20
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.9
6.2
24
64
H01AC01
ATC
somatropin; parenteral
5.1
6.2
18
36
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.1
6.1
31
103
5604
FHL
Vascular preparation or cannulation in the operating room
12.7
6.1
10
8
WX892
NOMESCO Finland
Monitored bed care
2.4
6.1
47
201
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
6.1
36
132
J01DB01
ATC
cefalexin; oral
1.6
6.0
504
4433
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
6.0
61
294
RD210
NOMESCO Finland
NA
3.0
6.0
32
110
205
Kela drug reimbursment
Chronic hypertension
1.9
6.0
93
534
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
411
1940
3.45
61.60
8.2
3.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
367
1701
3.25
55.14
8.1
3.1
e6/l
22.3
47.0
2.17
314
1275
(3000850) Epithelial cells [#/volume] in Urine
286
1156
3.37
53.82
6.2
2.5
e6/l
6.7
7.7
0.38
267
1011
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
246
923
3.47
51.95
5.2
2.6
e6/l
0.7
0.8
0.25
166
495
(3030467) Casts [#/volume] in Urine by Automated count
340
1560
3.14
51.10
7.7
2.9
e6/l
0.2
0.3
1.63
289
1147
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
238
889
3.45
50.44
5.6
2.8
e6/l
3.5
2.7
0.45
159
466
(36304419) Bacteria [Presence] in Urine
335
1562
3.05
48.35
7.7
2.9
—
—
—
0
0
(3026782) Osmolality of Urine
267
1095
3.22
48.21
6.2
2.6
mosm/kgh2o
549.7
568.9
0.67
243
938
(3018095) Leukocytes [#/volume] in Urine
403
2090
2.98
47.77
9.3
3.6
e6/l
65.0
53.6
0.40
322
1381
(3026008) Bacteria identified in Urine by Culture
346
1681
2.95
45.78
4.8
2.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
134
366
4.23
44.58
10.8
4.3
ng/l
103.5
67.6
3.68
127
339
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
17
18.33
36.98
7.3
11.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
32
22
15.14
35.83
3.2
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
590
4100
2.99
35.32
8.4
4.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
64
114
6.04
34.96
2.3
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
564
3919
2.72
32.04
9.0
4.1
e6/l
190.8
842.2
0.48
19
52
(3003458) Phosphate [Moles/volume] in Serum or Plasma
174
735
2.78
27.93
20.4
7.1
mmol/l
1.2
1.1
0.70
168
691
(3035350) Ketones [Presence] in Urine by Test strip
448
2932
2.29
26.85
6.0
3.3
estimate
0.0
0.0
0.00
75
589
(3009261) Glucose [Presence] in Urine by Test strip
452
2981
2.28
26.43
6.1
3.3
estimate
0.0
0.0
0.80
76
585
(3021601) Nitrite [Presence] in Urine by Test strip
446
2952
2.24
25.48
8.7
4.5
estimate
0.0
0.0
0.00
74
605
(3024561) Albumin [Mass/volume] in Serum or Plasma
347
2108
2.19
24.18
9.5
5.1
g/l
36.0
37.0
2.39
330
1970
(3044640) Blood type and Crossmatch panel - Blood
301
1752
2.19
23.12
2.6
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
249
1357
2.24
22.39
4.9
3.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
23
21
11.26
21.63
4.3
2.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
131
556
2.64
20.37
5.2
4.8
%
1.6
1.7
0.21
126
511
(3002032) Base excess in Venous blood by calculation
137
596
2.59
20.25
12.5
6.5
mmol/l
1.0
1.6
1.30
116
469
(3000991) Gas panel - Venous blood
127
544
2.60
19.33
14.5
9.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
379
2547
1.98
18.57
17.9
7.0
mmol/l
1.2
1.2
0.13
351
2180
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
106
430
2.70
17.93
10.8
7.4
mmol/l
23.5
23.9
1.09
99
408
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
16
11
14.84
17.66
7.4
6.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
11
14.84
17.66
6.6
6.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
390
2680
1.94
17.56
4.3
4.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
95
378
2.73
16.65
3.0
3.6
e9/l
67.7
72.0
0.55
69
277
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
50
137
3.84
16.20
12.8
7.3
iu/ml
700.4
447.8
0.19
12
19
(3023368) Bacteria identified in Blood by Culture
215
1235
2.03
16.02
6.7
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
279
1781
1.90
15.11
6.9
6.6
inr
1.0
1.1
3.97
56
572
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
136
668
2.26
15.09
6.8
2.3
%
20.7
23.5
1.78
119
588
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
343
2340
1.85
15.04
17.2
6.8
mmol/l
1.2
1.2
0.31
322
2138
(3022948) Iron [Moles/volume] in Serum or Plasma
151
785
2.15
14.53
6.2
2.3
umol/l
12.0
14.2
4.32
145
720
(3018418) pH of Serum or Plasma
239
1468
1.92
14.43
10.2
3.4
ph
7.4
7.4
1.79
37
272
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
119
3.77
13.74
4.2
9.7
u/ml
0.2
0.3
4.46
22
69
(3013826) Glucose [Moles/volume] in Serum or Plasma
429
3206
1.78
13.30
7.6
4.8
mmol/l
6.3
6.3
0.14
386
2902
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
32
73
4.53
13.19
1.7
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
55
184
3.14
13.13
2.8
1.6
u/ml
92.2
107.9
—
6
26
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
57
196
3.06
12.99
2.9
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
218
1345
1.87
12.73
2.6
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
249
1605
1.82
12.62
5.3
3.3
mmol/l
7.3
8.2
2.31
230
1380
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
61
222
2.90
12.59
2.2
1.5
u/ml
217.5
221.4
0.03
37
118
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
61
226
2.85
12.19
2.2
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
58
209
2.92
12.18
9.3
12.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
93
436
2.29
11.40
9.1
8.9
mmol/l
0.3
1.1
1.30
68
346
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
92
431
2.29
11.30
9.1
9.0
kpa
5.0
5.1
1.09
85
413
(3027801) Oxygen [Partial pressure] in Arterial blood
92
431
2.29
11.30
9.1
8.9
kpa
14.3
13.1
0.93
85
415
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
693
6167
2.46
11.24
21.6
11.5
mg/l
25.9
21.1
3.09
573
4606
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
8
20.39
11.16
8.9
8.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
31
79
4.05
11.11
9.2
2.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
359
2653
1.67
10.73
6.1
6.0
umol/l
13.2
11.8
0.48
334
2483
(3037121) Protein [Mass/volume] in Urine
56
215
2.73
10.47
6.3
5.0
g/l
0.2
0.3
0.89
41
113
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
49
178
2.87
10.16
1.7
2.4
g/l
1.7
1.4
1.04
41
155
(1616796) Gas panel - Central venous blood
34
99
3.55
10.12
8.4
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
183
1146
1.79
9.86
5.2
3.3
mg/l
95.3
169.8
0.48
148
764
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
505
4128
1.67
9.78
10.1
6.6
u/l
87.9
81.6
1.54
489
3854
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
19
7.49
9.72
2.3
2.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
664
5883
2.05
9.66
25.2
12.3
mmol/l
139.6
139.6
0.08
654
5699
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
311
2261
1.64
9.59
6.4
3.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
633
5529
1.88
9.47
26.6
14.3
%
13.6
13.4
1.86
628
5428
(40758558) Short blood count panel - Blood
236
1605
1.68
9.41
8.9
7.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
376
2879
1.61
9.29
9.8
6.9
%
0.7
0.7
0.07
361
2716
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
104
552
2.02
9.26
2.3
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
449
3593
1.61
9.19
11.8
9.2
e9/l
4.0
3.9
0.63
395
3119
(3023103) Potassium [Moles/volume] in Serum or Plasma
663
5903
1.99
9.02
25.7
12.3
mmol/l
4.0
3.9
4.37
651
5692
(3041096) Erythrocytes [Presence] in Urine by Automated
245
1699
1.65
8.99
5.7
2.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
186
1200
1.73
8.94
6.0
4.1
mg/mmol
17.5
10.6
1.50
148
782
(3019069) Monocytes/100 leukocytes in Blood
385
2991
1.58
8.76
9.9
7.0
%
8.6
8.3
1.16
370
2832
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
267
1908
1.62
8.61
3.3
3.3
u/l
29.6
30.8
0.34
256
1810
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
560
1.97
8.56
2.4
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
178
1150
1.72
8.46
4.2
2.9
umol/l
6883.2
4857.2
0.21
166
1011
(3002030) Lymphocytes/100 leukocytes in Blood
396
3115
1.57
8.41
9.6
6.7
%
29.3
30.8
1.81
378
2950
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
32
102
3.23
8.31
1.4
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
380
2972
1.56
8.20
9.8
6.8
%
2.9
2.8
0.29
364
2796
(3018010) Neutrophils/100 leukocytes in Blood
391
3078
1.56
8.20
9.2
6.5
%
55.7
54.7
0.96
374
2922
(3006184) Hemoglobin [Mass/volume] in Capillary blood
34
114
3.08
8.13
2.8
2.1
g/l
126.0
130.9
0.68
28
83
(3024928) Oxygen saturation in Venous blood
33
109
3.12
8.09
3.8
6.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
229
1597
1.62
8.06
3.5
2.5
u/l
63.3
55.0
2.52
216
1463
(42870588) Differential panel, method unspecified - Blood
287
2113
1.58
8.04
9.0
6.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
79
3.51
8.01
7.1
5.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
33
111
3.06
7.86
2.8
2.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
51
216
2.46
7.86
5.7
4.6
%
0.7
0.7
0.31
51
211
(3006315) Basophils [#/volume] in Blood
395
3136
1.54
7.84
9.4
6.7
e9/l
0.0
0.0
0.28
346
2705
(3047181) Lactate [Moles/volume] in Blood
34
117
3.00
7.79
8.4
9.5
mmol/l
1.3
1.2
0.22
28
99
(3013115) Eosinophils [#/volume] in Blood
405
3236
1.54
7.78
9.7
7.1
e9/l
0.2
0.2
0.36
359
2842
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
50
211
2.47
7.76
8.1
11.0
mmol/l
23.6
24.3
0.90
50
200
(3001604) Monocytes [#/volume] in Blood
393
3125
1.54
7.68
9.5
6.7
e9/l
0.6
0.6
1.25
343
2695
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
317
2408
1.54
7.63
3.8
2.4
nmol/l
71.8
72.4
0.16
309
2197
(3012095) Magnesium [Moles/volume] in Serum or Plasma
130
792
1.77
7.54
9.2
5.3
mmol/l
0.8
0.8
2.49
124
744
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
112
656
1.83
7.40
3.3
4.0
umol/l
9.6
7.3
0.30
93
547
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
129
790
1.76
7.34
2.4
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
127
2.84
7.31
2.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
158
2.62
7.12
3.9
3.2
—
—
—
0
0
(3016750) Collection duration of Urine
13
23
5.73
7.08
2.6
2.7
min
512.8
511.4
0.02
13
14
(3019198) Lymphocytes [#/volume] in Blood
403
3258
1.51
7.05
9.5
6.6
e9/l
2.0
2.0
0.26
357
2875
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
127
2.76
6.75
2.2
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
64
325
2.06
6.43
18.4
7.8
kpa
9.7
9.4
0.65
64
304
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
86
485
1.87
6.39
15.0
6.8
mmol/l
1.4
1.3
0.05
61
355
(3015377) Calcium [Moles/volume] in Serum or Plasma
228
1662
1.53
6.39
5.7
3.0
mmol/l
2.4
2.4
0.66
204
1482
(3000330) Specific gravity of Urine by Test strip
49
225
2.26
6.33
5.1
3.0
—
—
—
0
0
(3009343) pH of Capillary blood
86
497
1.82
5.92
15.3
6.8
ph
7.4
7.4
0.76
14
33
(3042936) Bacteria identified in Isolate by Culture
115
723
1.70
5.92
2.1
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
79
448
1.85
5.77
2.1
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
13
28
4.71
5.75
2.8
2.7
ml
621.5
493.8
0.51
13
15
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
91
542
1.77
5.67
2.7
2.3
u/l
48.5
31.0
0.87
80
444
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
137
913
1.61
5.61
3.7
3.4
ng/l
301.9
543.7
0.52
96
572
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
65
349
1.94
5.61
2.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
29
111
2.68
5.53
6.6
3.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
47
3.68
5.50
4.9
4.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
19
57
3.39
5.47
4.6
3.9
—
—
—
0
0
(3036489) Thrombin time
53
267
2.06
5.46
2.4
4.9
s
21.5
21.8
0.17
48
252
(3001122) Ferritin [Mass/volume] in Serum or Plasma
374
3082
1.42
5.35
4.5
2.9
ug/l
85.4
81.4
0.23
361
2872
(3022621) pH of Urine by Test strip
62
334
1.93
5.30
3.7
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
582
5209
1.51
5.28
18.3
9.8
ml/min/173m2
84.2
93.5
9.45
462
4032
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
31
4.25
5.10
3.5
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
691
6463
1.79
4.95
18.8
10.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
29
4.19
4.64
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
181
1338
1.46
4.54
6.4
3.5
kg/l
1.0
1.0
0.26
38
178
(3017143) Hepatitis C virus Ab [Presence] in Serum
150
1068
1.50
4.54
2.5
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
39
3.64
4.50
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
408
3482
1.37
4.41
3.4
3.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
50
3.25
4.35
1.9
2.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
108
2.46
4.26
9.4
3.0
mmol/l
1.5
2.5
1.24
15
62
(3019060) Gas panel - Arterial blood
45
235
1.97
4.25
9.2
6.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
16
51
3.18
4.22
1.9
2.6
mmol/l
4.1
4.0
0.82
16
51
(3035285) Chloride [Moles/volume] in Venous blood
16
51
3.18
4.22
1.9
2.6
mmol/l
107.0
105.9
0.41
16
51
(3035637) Corticotropin [Mass/volume] in Plasma
27
115
2.40
4.20
1.9
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
216
1671
1.41
4.20
2.3
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
32
3.79
4.09
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
37
3.56
4.06
2.2
2.6
u/field
1.4
2.4
—
7
22
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
7
10.08
4.01
1.7
1.4
umol/24h
264.6
251.4
—
7
7
(4035726)
65
390
1.73
3.98
1.7
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
44
234
1.93
3.96
11.8
8.4
mmol/l
23.0
24.5
1.83
37
218
(3009542) Hematocrit [Volume Fraction] of Blood
650
6054
1.52
3.92
23.4
12.4
%
38.5
40.2
5.61
534
4888
(3045788) Cell count panel - Pleural fluid
10
24
4.21
3.89
2.3
1.3
—
—
—
0
0
(44790048)
22
90
2.49
3.74
1.9
1.8
—
—
—
0
0
(44790047)
22
90
2.49
3.74
1.9
1.8
—
—
—
0
0
(44806118)
22
90
2.49
3.74
1.9
1.8
—
—
—
0
0
(44790049)
22
90
2.49
3.74
1.9
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
276
1.83
3.72
1.5
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
61
367
1.72
3.71
6.4
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
145
1066
1.45
3.70
1.5
1.4
nmol/l
20.5
20.4
0.01
136
907
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
59
352
1.73
3.70
4.5
2.4
ml/min/173m2
52.8
74.5
2.15
26
135
(3011648) Oxygen content in Venous blood
14
45
3.15
3.66
3.4
11.6
%
9.9
12.3
2.74
14
45
(3020630) Protein [Mass/volume] in Serum or Plasma
53
309
1.77
3.60
2.8
2.9
g/l
65.4
66.6
0.44
53
285
(3045414) Leukocytes [Presence] in Urine
42
228
1.89
3.58
1.8
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
98
670
1.53
3.57
1.8
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
31
3.59
3.49
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
78
510
1.59
3.46
4.4
2.7
—
—
—
0
0
(3024471) HLA-A [Type]
11
32
3.47
3.34
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
294
1.75
3.32
1.7
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
251
2060
1.33
3.23
1.9
1.9
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
8
15
5.38
3.19
6.5
11.1
%
45.0
48.2
—
8
15
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
40
225
1.82
3.09
2.2
1.6
g/l
1.1
1.2
0.47
40
213
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
39
218
1.83
3.07
2.2
1.6
g/l
0.2
0.2
0.01
39
207
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
133
2.07
3.04
1.6
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
727
7020
1.90
3.04
30.2
16.7
e9/l
255.3
258.3
0.66
713
6819
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
81
2.38
3.00
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
121
2.10
2.95
2.5
2.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
82
2.35
2.93
1.2
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
63
409
1.59
2.91
17.6
7.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
122
2.08
2.90
5.6
3.8
mg/l
26.6
27.6
0.06
20
79
(3026361) Erythrocytes [#/volume] in Blood
727
7029
1.86
2.89
30.1
16.6
e12/l
4.5
4.6
2.00
712
6817
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
102
2.19
2.89
3.6
2.5
ug/min
124.7
101.9
0.11
15
60
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
22
4.13
2.89
3.7
6.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
9
6.71
2.87
1.2
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
9
6.71
2.87
1.5
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
727
7031
1.85
2.86
30.1
16.6
e9/l
6.8
6.7
0.92
714
6816
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
34
187
1.86
2.83
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
12
42
2.89
2.76
3.2
2.8
nmol/l
0.7
0.8
0.65
12
30
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
219
1.77
2.74
1.8
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
37
3.00
2.70
2.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
157
1233
1.34
2.68
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
89
636
1.45
2.65
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
37
214
1.77
2.64
1.2
1.5
—
8.7
—
0
7
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
61
2.49
2.63
1.3
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
23
114
2.05
2.58
3.2
2.3
g/l
0.4
0.6
0.16
23
106
(3014148) Varicella zoster virus Ab [Titer] in Serum
26
137
1.93
2.48
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
123
1.98
2.47
3.0
2.1
g/l
9.8
10.0
0.12
24
111
(3039443) Prostate specific Ag panel - Serum or Plasma
13
51
2.58
2.45
1.1
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
48
305
1.61
2.45
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
189
1.78
2.45
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
333
2914
1.25
2.45
13.1
9.1
e9/l
0.0
0.0
0.24
267
2339
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
184
1497
1.30
2.44
2.8
2.3
mg/l
3.1
2.9
0.40
162
1289
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
132
1.92
2.38
3.0
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
111
844
1.37
2.33
1.4
1.4
titre
368.4
556.6
1.03
19
151
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
169
1369
1.30
2.31
1.7
1.7
mmol/l
1.4
1.3
0.47
159
1166
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
92
2.09
2.28
1.9
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
192
1588
1.28
2.24
7.6
3.5
estimate
0.0
0.0
0.88
68
587
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
150
1.83
2.23
2.4
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
28
159
1.79
2.16
2.7
3.1
u/ml
369.1
1025.4
0.32
19
136
(3025941) Bacteria identified in Stool by Culture
53
358
1.52
2.11
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
37
2.73
2.11
1.4
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
10
5.02
2.07
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
76
2.13
2.03
2.1
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
34
209
1.66
2.01
1.1
2.1
u/l
35.0
39.5
0.89
28
191
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
32
2.83
2.00
1.1
1.1
iu/ml
357.3
151.8
—
9
32
(3005033) Fetal Nuchal fold Thickness US
45
297
1.55
2.00
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
244
2102
1.24
1.98
2.6
2.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
299
1.54
1.95
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
150
1.76
1.93
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
150
1.76
1.93
2.4
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
39
2.58
1.92
1.6
4.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
128
1025
1.30
1.91
2.4
2.6
ug/g
115.8
117.9
0.03
99
804
(21494890) Protein electrophoresis panel - 24 hour Urine
8
28
2.88
1.86
1.3
3.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
86
2.00
1.86
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
122
1.83
1.86
1.9
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
91
697
1.35
1.85
2.2
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
59
2.22
1.85
5.3
2.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
17
3.55
1.84
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
191
1.65
1.83
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
502
4673
1.22
1.83
5.8
4.6
mmol/mol
37.7
38.1
0.43
478
4380
(40768806) Pleura Pathology biopsy report
8
29
2.78
1.79
2.8
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
590
5591
1.25
1.78
4.9
4.4
mu/l
1.9
1.8
1.18
559
5176
(3013707) Erythrocyte sedimentation rate by Westergren method
462
4274
1.21
1.76
4.7
3.8
mm/h
10.7
9.6
0.99
443
3925
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
19
103
1.87
1.73
1.2
1.2
u/ml
1.0
3.2
—
6
43
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
376
1.44
1.70
3.5
4.3
ug/l
4.0
18.0
0.65
44
304
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
72
540
1.37
1.69
1.2
1.2
iu/ml
102.3
140.8
0.74
26
205
(3004588) Protein electrophoresis panel - Serum or Plasma
35
228
1.56
1.68
2.5
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
114
916
1.29
1.67
1.7
1.6
pmol/l
119608300.4
34710111.1
0.32
102
775
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
25
2.82
1.65
3.3
6.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
55
397
1.42
1.62
1.7
1.6
mu/l
385.3
306.6
0.34
50
359
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
14
3.59
1.61
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
5
14
3.59
1.61
1.8
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
86
669
1.32
1.60
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
77
1.97
1.60
1.4
1.6
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
26
2.71
1.58
1.6
1.8
iu/ml
—
1224630.0
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
88
689
1.31
1.57
2.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
220
1918
1.21
1.55
1.8
1.7
pmol/l
95.3
97.6
0.30
113
988
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
33
2.44
1.54
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
568
5390
1.21
1.53
4.6
3.9
mmol/l
2.7
2.8
2.07
546
5017
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
132
1092
1.25
1.53
3.6
3.5
ng/l
2115.3
856.9
1.36
122
898
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
93
1.85
1.52
2.5
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
509
4784
1.19
1.51
4.4
3.8
pmol/l
14.8
14.5
1.56
477
4326
(40760888) Immunoglobulin light chains.free panel - Serum
13
65
2.02
1.49
3.9
4.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
60
448
1.37
1.47
2.7
2.7
ug/l
0.8
0.7
0.41
40
272
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
16
87
1.86
1.46
3.4
4.2
—
3.7
—
0
7
(3006462) Nitrate [Presence] in Urine
7
28
2.51
1.45
2.7
3.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
16
3.14
1.44
1.0
4.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
50
364
1.40
1.43
1.8
1.6
iu/l
41.0
18.6
1.81
40
281
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
382
1.39
1.41
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
383
1.38
1.39
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
80
631
1.30
1.37
4.0
4.0
%
22.6
21.0
0.40
36
268
(3012565) Volume of 24 hour Urine
6
23
2.62
1.37
2.7
2.2
ml
2411.7
2493.3
—
6
23
(3003694) ABO and Rh group [Type] in Blood
232
2054
1.19
1.36
1.7
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
54
714
0.74
1.36
1.2
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
57
428
1.36
1.36
1.5
1.5
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
17
2.95
1.36
1.0
1.1
mg/g
4.7
6.1
—
5
17
(3003327) Ova and parasites identified in Stool by Light microscopy
40
283
1.44
1.34
1.7
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
47
2.14
1.34
5.0
5.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
386
1.37
1.34
2.3
2.4
e9/l
3.8
4.1
0.55
46
328
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
656
6345
1.25
1.32
13.0
8.8
u/l
24.8
25.9
0.98
642
6118
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
424
3950
1.17
1.31
3.5
3.1
u/l
37.2
36.8
0.04
399
3746
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
76
1.86
1.30
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
243
0.57
1.30
1.2
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
34
2.37
1.29
1.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
12
62
1.95
1.28
1.0
1.2
u/l
11.4
20.4
0.92
12
54
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
62
1.95
1.28
1.5
1.7
—
—
—
0
0
(4027681)
10
48
2.10
1.28
1.0
1.3
—
—
—
0
0
(4306422)
15
84
1.80
1.27
1.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
51
381
1.36
1.27
1.5
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.30
1.27
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
35
2.30
1.27
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
44
2.06
1.27
1.6
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
51
382
1.36
1.25
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
52
391
1.35
1.25
7.0
4.7
%
0.0
0.1
0.82
21
91
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
139
1185
1.21
1.23
1.7
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
63
1.92
1.23
2.2
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
56
1.98
1.22
1.2
1.3
nmol/l
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
86
697
1.26
1.21
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
148
1.57
1.21
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
250
0.59
1.21
1.2
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
143
1229
1.20
1.17
2.1
2.4
mg/l
1.8
1.0
0.41
114
900
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
543
5181
1.17
1.16
4.1
3.6
mmol/l
5.7
5.7
0.40
507
4744
(4211845)
7
30
2.35
1.12
2.7
3.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
11
58
1.91
1.12
1.0
1.2
mg/l
34.4
36.5
0.09
11
44
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
51
1.97
1.11
1.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
155
1349
1.19
1.11
2.0
2.2
u/l
147.7
231.5
0.92
148
1273
(3020393) Adenovirus Ag [Presence] in Stool
7
31
2.27
1.10
1.9
2.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
185
1635
1.17
1.10
3.2
3.2
ng/l
37.0
33.4
0.10
95
913
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
2.2
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
21
2.39
1.09
1.4
2.4
ug/l
200.4
126.9
—
5
21
(3000012) Reticulocyte production index
5
21
2.39
1.09
1.0
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
21
2.39
1.09
2.2
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
211
1.44
1.07
1.4
1.6
iu/ml
1.0
0.1
—
10
38
(3023511) Choriogonadotropin [Units/volume] in Urine
43
323
1.35
1.06
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
33
2.13
1.05
1.7
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
32
230
1.41
1.03
2.4
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
98
824
1.22
1.01
3.7
2.6
mmol/l
2.4
2.4
0.04
81
713
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
107
0.46
1.01
1.8
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
21
139
1.53
1.01
6.7
3.6
nmol/l
24.0
23.3
0.08
21
134
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
35
2.01
1.00
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
19
124
1.55
0.97
1.1
1.1
u/ml
6.0
1.8
—
7
52
(3017181) Myelocytes/100 leukocytes in Blood
54
426
1.29
0.97
7.0
4.5
%
0.5
0.9
1.17
26
119
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
36
1.95
0.97
1.0
1.3
—
—
—
0
0
(3000492) Spirometry study
67
544
1.25
0.96
1.7
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
552
5303
1.15
0.96
4.3
3.5
mmol/l
1.4
1.5
0.77
532
4955
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
555
5336
1.15
0.95
4.4
3.6
mmol/l
4.5
4.6
2.15
536
5011
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
101
1.60
0.94
1.3
1.2
u/ml
2.4
4.0
—
7
47
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
70
1.73
0.93
1.1
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
529
0.76
0.92
9.8
5.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
78
1.68
0.92
1.5
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
50
394
1.29
0.92
6.9
4.1
%
0.4
0.4
0.05
17
83
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
95
807
1.20
0.90
4.7
4.4
ug/l
2.2
2.2
0.02
90
716
(3012441) Differential panel - Pleural fluid
6
29
2.08
0.89
1.7
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
56
1.80
0.88
2.0
1.7
pg
32.7
32.1
—
10
56
(3020491) Glucose [Moles/volume] in Blood
8
43
1.87
0.87
2.1
1.8
mmol/l
5.3
6.0
—
8
31
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
43
1.87
0.87
2.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
44
1.83
0.86
6.3
4.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
96
1.57
0.84
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
57
1.76
0.84
1.1
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
528
5077
1.13
0.84
3.9
3.3
mmol/l
1.2
1.2
0.46
509
4738
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
65
1.70
0.82
1.8
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
73
1.65
0.82
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
29
215
1.36
0.81
1.1
1.1
u/ml
14.7
7.0
—
6
38
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
207
1.37
0.80
1.9
3.0
umol/l
7.2
6.8
0.07
22
163
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
549
5298
1.13
0.80
3.7
3.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
58
1.73
0.80
1.3
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
304
1.30
0.79
1.4
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
50
403
1.26
0.79
7.4
4.6
%
0.0
0.1
0.73
25
107
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
174
0.63
0.77
1.5
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
34
1.77
0.76
2.0
1.6
g/l
0.9
0.9
—
6
34
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
534
1.22
0.75
1.1
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.72
2.6
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
229
1.32
0.72
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
76
1.59
0.72
2.7
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
41
1.71
0.70
1.9
3.4
umol/l
27.4
24.3
—
7
41
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
152
1.39
0.69
1.1
2.4
e6/l
1.7
6.1
1.74
16
115
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
21
152
1.39
0.69
1.1
2.4
e6/l
410.6
236.4
0.25
16
119
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
2.8
2.7
mg/l
9.4
10.9
—
5
21
(1002224) Polysomnography panel
28
215
1.31
0.66
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
21
155
1.36
0.63
1.2
1.1
—
5.8
—
0
11
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
104
1.45
0.62
2.3
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
157
1432
1.12
0.61
8.9
4.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
30
1.67
0.61
1.4
2.6
—
1401.0
—
0
5
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
88
1.49
0.61
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
51
1.57
0.60
1.4
2.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.1
2.8
nmol/l
4.0
3.1
—
8
51
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
18.7
—
0
6
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
92.7
—
0
14
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
183
1.32
0.60
1.3
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
80
1.51
0.60
1.3
3.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
68
589
1.17
0.57
2.3
2.3
u/l
7476.2
4491.7
0.38
28
228
(3025130) Human papilloma virus identified in Specimen
14
98
1.44
0.56
1.8
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
221
2066
1.10
0.55
1.8
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
38
1.58
0.54
4.7
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
61
1.48
0.54
2.6
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
117
1.38
0.52
6.6
3.6
e9/l
3.2
3.9
0.73
16
117
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
40
1.50
0.51
1.2
1.1
%
70.0
85.5
—
6
40
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
9
64
1.41
0.51
2.0
1.5
mosm/kgh2o
292.6
286.8
—
9
42
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
171
1.29
0.50
1.8
1.8
iu/l
3.0
6.2
—
8
54
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
88
786
1.14
0.50
1.5
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
145
1.32
0.49
1.4
1.3
ug/g
236.6
351.0
1.46
14
82
(3010726) Horse dander IgE Ab [Units/volume] in Serum
18
233
0.77
0.47
1.1
1.2
u/ml
6.3
3.7
—
7
74
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.1
—
83.8
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.1
—
45.6
—
0
5
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
77
1.43
0.45
1.4
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
57
498
1.16
0.45
1.5
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
56
1.43
0.42
1.3
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
122
1.32
0.42
9.2
3.6
%
49.8
54.9
0.65
16
122
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
32
1.57
0.42
10.2
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
63
559
1.14
0.41
1.3
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
7.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
123
1.31
0.40
1.3
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.1
miu/ml
1529.6
1721.3
—
5
34
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.1
—
0
13
(3007164) IgA [Mass/volume] in Serum or Plasma
183
1723
1.08
0.39
1.6
1.5
g/l
2.0
2.0
0.31
113
1001
(3005082) Progesterone [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
1.5
1.3
nmol/l
30.6
38.3
—
8
52
(4062490)
10
71
1.41
0.39
1.5
1.3
—
—
—
0
0
(4268621)
10
71
1.41
0.39
2.6
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
334
0.83
0.39
1.4
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
63
562
1.13
0.39
8.5
3.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
243
1.20
0.38
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
68
1.33
0.37
1.3
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
170
1.24
0.37
1.9
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
70
1.29
0.36
1.0
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
234
0.81
0.36
1.1
1.2
u/ml
1.9
1.4
0.18
12
145
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
543
0.88
0.36
4.0
3.5
%
32.5
32.1
0.09
41
376
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
73
1.37
0.34
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
73
1.37
0.34
1.4
1.2
—
—
—
0
0
(4010399)
41
360
1.15
0.33
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
128
1.26
0.32
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
47
418
1.13
0.32
8.7
3.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
101
1.29
0.32
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
262
0.83
0.31
1.0
1.3
u/ml
0.5
2.3
1.66
12
144
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
115
1074
1.08
0.31
2.0
2.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
201
1917
1.07
0.31
1.4
1.4
u/ml
1.1
1.7
0.78
46
460
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
42
371
1.14
0.31
1.4
1.3
miu/ml
240.2
253.6
0.08
19
190
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
25
293
0.85
0.30
3.6
2.4
u/ml
24.8
45.3
1.12
25
281
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
54
1.30
0.30
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
75
1.34
0.30
3.8
3.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
55
1.28
0.30
1.1
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
121
1.24
0.28
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
28
322
0.86
0.28
1.7
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
66
1.21
0.26
1.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
66
1.21
0.26
1.3
2.6
—
—
—
0
0
(4094501)
12
95
1.27
0.26
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
105
1.24
0.25
1.4
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
142
1.20
0.24
1.1
2.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
48
437
1.10
0.24
2.0
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
162
1.18
0.23
1.1
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
5
40
1.25
0.22
1.0
1.0
mu/l
10.8
9.8
—
5
35
(3002523) Influenza virus A Ag [Presence] in Specimen
19
163
1.17
0.21
1.1
1.1
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
68
634
1.08
0.21
1.7
1.5
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
26.9
—
0.5
—
0
13
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
117
1.20
0.20
1.4
1.1
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
4.3
—
0
8
(3008536) Aspergillus sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
136
1.18
0.20
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
64
598
1.08
0.19
2.1
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
31
343
0.90
0.19
1.6
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
52
1.15
0.19
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
52
1.15
0.19
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
100
1.20
0.18
2.3
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
153
0.85
0.18
1.1
1.1
u/ml
13.5
7.0
—
8
82
(3000093) Morphology [Interpretation] in Blood Narrative
7
59
1.19
0.18
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
205
0.87
0.17
1.1
1.5
—
—
—
0
0
(4198724)
7
62
1.13
0.17
1.7
2.0
—
—
—
0
0
(3013512) EKG study
130
1250
1.05
0.17
3.9
3.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
93
886
1.06
0.17
1.9
1.6
%
1.4
1.4
0.16
88
803
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
955
1.05
0.17
1.3
1.3
iu/ml
14.0
25.5
2.63
28
276
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
69
0.72
0.17
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
130
0.84
0.16
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
145
1401
1.04
0.16
1.9
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
53
497
1.07
0.15
2.0
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
58
614
0.94
0.14
1.7
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
89
0.78
0.14
1.6
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
170
1748
0.96
0.14
2.1
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
431
1.07
0.14
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
237
1.10
0.14
1.8
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
84
1.19
0.14
1.1
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
41
437
0.93
0.13
2.4
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
92
887
1.04
0.11
1.8
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
27
291
0.93
0.11
2.6
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
18
164
1.10
0.09
11.8
4.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
46
1.09
0.09
1.0
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
176
0.91
0.09
1.8
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
58
1.03
0.08
1.7
2.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
71
0.84
0.07
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
71
0.84
0.07
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
70
0.86
0.07
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
70
0.86
0.07
1.8
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
70
0.86
0.07
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
70
0.86
0.07
1.8
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
75
0.80
0.07
3.0
4.6
u/ml
104.5
380.4
—
6
70
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
13
143
0.91
0.07
1.5
1.6
nmol/l
0.3
0.4
0.19
13
122
(3027944) Amphetamines [Presence] in Urine
66
639
1.04
0.07
2.1
1.9
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
94
0.85
0.06
5.9
5.3
umol/l
374.6
400.8
—
8
85
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
36
376
0.96
0.06
1.4
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
102
0.88
0.06
1.4
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
31
324
0.95
0.05
1.4
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
29
303
0.96
0.05
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
159
1611
0.98
0.05
2.0
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
66
644
1.03
0.05
2.1
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
328
1.04
0.04
1.8
1.7
u/l
15.8
8.0
0.86
28
248
(3028300) Cannabinoids [Presence] in Urine
66
646
1.02
0.04
2.2
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
200
1.05
0.03
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
121
1.08
0.03
1.4
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
191
1.05
0.03
2.0
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
65
639
1.02
0.02
2.1
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
178
0.95
0.02
1.9
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
94
929
1.01
0.02
1.3
1.2
u/ml
13.3
8.7
0.19
32
361
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
202
1.04
0.02
1.2
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
74
734
1.01
0.00
1.6
1.6
nmol/l
1342.8
1188.6
0.42
59
565
(42529406) Shigella sp [Presence] in Stool by Culture
21
205
1.02
0.00
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
298
1.01
0.00
1.4
1.8
mg/l
3.9
3.4
0.13
17
198
(1761868) Lipid panel - Serum or Plasma
202
2024
1.00
0.00
2.7
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
498
1.00
0.00
1.3
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
179
1.01
0.00
1.3
1.6
nmol/l
40.4
39.8
0.05
18
174
(3013139) Helicobacter pylori Ag [Presence] in Stool
39
392
0.99
0.00
1.2
1.2
—
—
—
0
0
(4034850)
16
159
1.01
0.00
6.0
8.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
118
1.02
0.00
2.1
2.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
109
1.01
0.00
1.4
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
108
1.02
0.00
1.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
24.3
—
0
9
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
32.7
—
0
9
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
55
0.91
0.00
1.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
50
1.00
0.00
1.4
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
55
0.91
0.00
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
12.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
270.8
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
73
0.96
0.00
3.3
4.9
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.6
1.3
—
—
—
0
0
(44813793)
5
58
0.86
0.00
1.4
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
99
0.91
0.00
1.2
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
20.7
—
0
5
(3037756) Immunofixation for Serum or Plasma
6
64
0.94
0.00
1.2
1.8
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
7
0.00
0.00
0.0
10.3
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER | 1.465 [1.2, 1.79] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.145 |
During the follow-up period (1.1.1998 — 31.12.2019), 184 out of 4672 females with Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER | 1.668 [1.31, 2.13] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 136 out of 4660 males with Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.093% | 0.297% |
| 5 | 0.765% | 1.81% |
| 10 | 1.936% | 4.479% |
| 15 | 3.673% | 8.582% |
| 20 | 6.517% | 15.033% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER – Congenital obstructive defects of renal pelvis and congenital malformations of ureter
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data